Mucopolysaccharidoses (MPS) Related News
Supporting patients and families with Mucopolysaccharidosis
Founded in 1985, MPS Austria supports children with Mucopolysaccharidosis and other similar Lysosomal diseases, and their families, by helping to increase quality of life.
MPS...
Understanding MPS and other similar Lysosomal diseases
MPS Austria wants to make everyday life easier for children with Mucopolysaccharidosis and other similar Lysosomal diseases, and their families, by supporting them with...
A spotlight on MPS Austria
Speaking to Health Europa, Michaela Weigl, the president of MPS Austria, discusses the society’s work to support people living with mucopolysaccharidoses and to raise...
MPS disease: the health benefits of cannabinoids to MPS patients
Over the last few decades, the health benefits of cannabinoids has become an increasingly popular topic, but can this help those with the rare...
Learn about Rare Disease Day with MPS Austria
Did you know that one in 20 people will live with a rare disease at some point in their life? 29 February 2020 marked...
Living with mucopolysaccharidoses: support, awareness and research
Mucopolysaccharidoses (MPS) is a group of rare, inherited, incurable metabolic diseases caused by disorders in the metabolism, in this eBook the Austrian MPS Society...
Everything you need to know about the annual MPS therapy week
From 11 July to 20 July 2019, the annual MPS therapy week and bi-annual MPS Conference was hosted in Hinterglemm, in the South-East of...
Light and shadow – daily life with Mucopolysaccharide storage disorders
Susanne Kircher, co-founder of the Austrian MPS Society, talks about the rare chronic diseases, mucopolysaccharide storage disorders.
Mucopolysaccharide storage disorders (MPS) are rare chronic diseases,...
Promising clinical research could revolutionise mucopolysaccharidosis treatment
According to research, mucopolysaccharidosis treatment is still emerging, but recent drug approval & promising clinical research studies could accelerate treatment pattern for those suffering.
Mucopolysaccharidosis...
Exploring mucopolysaccharide storage disorders
Susanne Gerit Kircher, Medical University of Vienna, argues that Europe must renew its efforts to tackle rare diseases such as mucopolysaccharide storage disorders.
Mucopolysaccharide storage...
Becoming reality – mucopolysaccharide storage diseases and adulthood
Susanne Gerit Kircher, of the Medical University of Vienna, explains why more resources and effort must be put into understanding mucopolysaccharide storage diseases in...
Mucopolysaccharide storage diseases and puberty and adolescence
The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
The Fool’s Tower: Europe’s oldest accommodation for mental patients
Health Europa explores with those involved in managing and expanding the then-hospital for mental patients, Vienna’s Narrenturm (Fool’s Tower).
In September, Health Europa travelled to...
The Swiss perspective on mucopolysaccharide disease
Dr Fredi Wiesbauer, vice president of the Swiss Mucopolysaccharide disease (MPS) Society met with Health Europa and explored the Swiss experience of hosting such...
Understanding mucopolysaccharide storage diseases
What are mucopolysaccharide storage diseases? What are their signs and symptoms? And what treatment options are available for patients?
These are just some of the...
How is MPS Austria improving understanding of mucopolysaccharidoses?
Professor Dr Dr Susanne Gerit Kircher discusses her work alongside the Austrian MPS Society towards a better understanding of mucopolysaccharidoses.
Speaking to Health Europa during...
Make Patients Smile: the MPS Austria Therapy Week mission
Continuing its coverage of the MPS Austria Therapy Week, Health Europa speaks to childcare organiser Anna Prähofer about how the event has evolved since...
The MPS Society: supporting those with mucopolysaccharidoses
Being diagnosed and living with mucopolysaccharidoses is life changing. The Austrian MPS Society, MPS Austria, is an organisation which supports families and their individuals...
Key areas of research in the diagnosis and treatment of MPS diseases
Professor Dr François Eyskens of PCMA vzw discusses early diagnosis of MPS diseases by creating awareness and using a tandem mass spectrometry screening method.
MPS...
Diagnosing mucopolysaccharidoses diseases in young people
This booklet was written by Professor Dr Francois Eyskens of the PCMA vzw, the metabolic laboratory, and the Center of Inherited Metabolic Diseases at...
